U.S. Flag An official website of the United States government

Colorectal Cancer Mortality Projections

Key Findings >

Question: When will we reach the Healthy People 2010 colorectal cancer mortality objective of 13.7 deaths per 100,000?

Answer: We used our simulation models to determine whether we are on track to meet the Healthy People 2010 objective for CRC mortality for the general population. Our models predict that given projected trends in risk factors, screening and chemotherapy, the mortality rate will be 15.1 per 100,000 for the general population. Even if those interventions are stepped up to a level we believe is optimistic but still realistic, the rate will be 14.5 in 2010. However, white women are likely to achieve the objective of 13.7 deaths per 100,000 before 2010, and white men and black women by 2020.


Detailed Discussion

Healthy People 2010 is a statement of national health objectives designed to identify the most significant preventable threats to health and to establish national goals to reduce these threats. It includes several objectives that apply to colorectal cancer (CRC), including one to reduce death due to CRC to 13.7 per 100,000 by 2010.

Healthy People 2010 (HP 2010) goals and objectives were set for the nation as a whole, and our simulations show that meeting the CRC mortality objective (the pink ‘+’ on the graph below) is unlikely by 2010. If current trends for risk factors, screening, and chemotherapy continue, we predict that mortality will be in the vicinity of 15.1 per 100,000 by 2010. If we are able to accelerate these interventions according to our Optimistic but Realistic scenario, the rate would be about 14.6 per 100,000. You can hold your cursor over the points on the graph below to see the projected numbers.

Graphs showing the Both Races, Both Sexes results for the combined (average) model. The scenarios displayed are the the projected trends baseline and Risk Factors, Screening and Chemotherapy (Optimistic Goals)Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2020 :  10.5Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2019 :  10.7Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2018 :  11.0Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2017 :  11.4Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2016 :  11.7Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2015 :  12.1Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2014 :  12.5Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2013 :  12.9Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2012 :  13.5Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2011 :  14.0Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2010 :  14.6Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2009 :  15.2Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2008 :  15.9Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2007 :  16.5Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2006 :  17.2Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2005 :  18.0Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2004 :  18.8Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2003 :  19.3Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2002 :  19.9Projected Trends Baseline - 2020 :  11.9Projected Trends Baseline - 2019 :  12.0Projected Trends Baseline - 2018 :  12.2Projected Trends Baseline - 2017 :  12.4Projected Trends Baseline - 2016 :  12.8Projected Trends Baseline - 2015 :  13.0Projected Trends Baseline - 2014 :  13.4Projected Trends Baseline - 2013 :  13.7Projected Trends Baseline - 2012 :  14.1Projected Trends Baseline - 2011 :  14.7Projected Trends Baseline - 2010 :  15.1Projected Trends Baseline - 2009 :  15.7Projected Trends Baseline - 2008 :  16.3Projected Trends Baseline - 2007 :  16.8Projected Trends Baseline - 2006 :  17.5Projected Trends Baseline - 2005 :  18.2Projected Trends Baseline - 2004 :  18.8Projected Trends Baseline - 2003 :  19.3Projected Trends Baseline - 2002 :  19.9US Vital Statistics - 2002 :  19.9US Vital Statistics - 2001 :  20.3US Vital Statistics - 2000 :  20.9Healthy People 2010 U.S. Target - 2010 :  13.7

Download: data | image[D]

If we look at CRC mortality by race and sex groups, we find that white females are very likely to meet the objective; black women and white men might achieve the objective sometime before 2020, assuming current trends in risk factors, screening and chemotherapy continue.

Graphs showing the comparison of White Females and Black Females for the Projected Trends Baseline (Baseline) scenario.Black Females - 2020 :  13.6Black Females - 2019 :  13.7Black Females - 2018 :  14.1Black Females - 2017 :  14.2Black Females - 2016 :  14.6Black Females - 2015 :  14.9Black Females - 2014 :  15.3Black Females - 2013 :  15.7Black Females - 2012 :  16.2Black Females - 2011 :  16.6Black Females - 2010 :  17.3Black Females - 2009 :  18.0Black Females - 2008 :  18.8Black Females - 2007 :  19.3Black Females - 2006 :  20.1Black Females - 2005 :  20.6Black Females - 2004 :  21.4Black Females - 2003 :  22.2Black Females - 2002 :  22.8White Females - 2020 :   9.8White Females - 2019 :   9.9White Females - 2018 :  10.0White Females - 2017 :  10.2White Females - 2016 :  10.4White Females - 2015 :  10.5White Females - 2014 :  10.8White Females - 2013 :  10.9White Females - 2012 :  11.3White Females - 2011 :  11.7White Females - 2010 :  12.0White Females - 2009 :  12.4White Females - 2008 :  12.9White Females - 2007 :  13.2White Females - 2006 :  13.8White Females - 2005 :  14.5White Females - 2004 :  15.0White Females - 2003 :  15.4White Females - 2002 :  16.0Black Females (US Vital Statistics) - 2002 :  22.8Black Females (US Vital Statistics) - 2001 :  24.2Black Females (US Vital Statistics) - 2000 :  23.9White Females (US Vital Statistics) - 2002 :  16.0White Females (US Vital Statistics) - 2001 :  16.5White Females (US Vital Statistics) - 2000 :  17.0Healthy People 2010 U.S. Target - 2010 :  13.7

Download: data | image[D]

Graphs showing the comparison of White Males and Black Males for the Projected Trends Baseline (Baseline) scenario.Black Males - 2020 :  22.4Black Males - 2019 :  22.5Black Males - 2018 :  23.0Black Males - 2017 :  23.3Black Males - 2016 :  23.8Black Males - 2015 :  24.3Black Males - 2014 :  24.8Black Males - 2013 :  25.3Black Males - 2012 :  26.0Black Males - 2011 :  26.6Black Males - 2010 :  27.2Black Males - 2009 :  27.9Black Males - 2008 :  28.8Black Males - 2007 :  29.3Black Males - 2006 :  30.3Black Males - 2005 :  31.1Black Males - 2004 :  31.8Black Males - 2003 :  32.7Black Males - 2002 :  33.4White Males - 2020 :  13.0White Males - 2019 :  13.2White Males - 2018 :  13.5White Males - 2017 :  13.7White Males - 2016 :  14.2White Males - 2015 :  14.6White Males - 2014 :  15.0White Males - 2013 :  15.4White Males - 2012 :  16.1White Males - 2011 :  16.7White Males - 2010 :  17.4White Males - 2009 :  18.1White Males - 2008 :  18.8White Males - 2007 :  19.7White Males - 2006 :  20.5White Males - 2005 :  21.3White Males - 2004 :  21.9White Males - 2003 :  22.6White Males - 2002 :  23.2Black Males (US Vital Statistics) - 2002 :  33.4Black Males (US Vital Statistics) - 2001 :  33.2Black Males (US Vital Statistics) - 2000 :  34.9White Males (US Vital Statistics) - 2002 :  23.2White Males (US Vital Statistics) - 2001 :  23.7White Males (US Vital Statistics) - 2000 :  24.4Healthy People 2010 U.S. Target - 2010 :  13.7

Download: data | image[D]

According to our models, the Healthy People 2010 objective for colorectal cancer deaths for black males is not obtainable even by 2020, regardless of intervention use. In the graph below, the red line shows the effect on CRC mortality of meeting the Optimistic but Realistic goals for upstream objectives. In this scenario, CRC mortality for black males would decrease to about 19.5 deaths per 100,000 by 2020, down from 22.4 under Projected Trends (black line) but still well above the HP 2010 goal of 13.7.

There are Healthy People objectives for increasing screening and addressing various risk factors (the ‘upstream objectives’ in our models). Because these objectives are set for the population as a whole, many are more aggressive than the optimistic goals we set for black males in our models, especially for certain risk factors like smoking and use of multivitamins. If black males were to reach the Healthy People 2010 upstream objectives (blue line), it may be possible to further reduce CRC mortality to around 17.2 deaths per 100,000.

Graphs showing the Black Males results for the combined (average) model. The scenarios displayed are the the projected trends baseline, Risk Factors, Screening and Chemotherapy (Optimistic Goals) and Risk Factors, Screening and Chemotherapy* (HP 2010 Goals)Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2020 :  17.2Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2019 :  17.8Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2018 :  18.4Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2017 :  19.1Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2016 :  20.0Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2015 :  21.1Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2014 :  22.0Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2013 :  22.8Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2012 :  24.0Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2011 :  24.7Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2010 :  25.7Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2009 :  26.8Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2008 :  27.7Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2007 :  28.3Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2006 :  29.1Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2005 :  30.3Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2004 :  31.8Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2003 :  32.8Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2002 :  33.4Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2020 :  19.5Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2019 :  19.8Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2018 :  20.4Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2017 :  20.8Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2016 :  21.5Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2015 :  22.3Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2014 :  23.1Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2013 :  23.5Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2012 :  24.5Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2011 :  25.2Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2010 :  26.0Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2009 :  27.0Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2008 :  27.9Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2007 :  28.4Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2006 :  29.2Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2005 :  30.4Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2004 :  31.7Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2003 :  32.7Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2002 :  33.4Projected Trends Baseline - 2020 :  22.4Projected Trends Baseline - 2019 :  22.5Projected Trends Baseline - 2018 :  23.0Projected Trends Baseline - 2017 :  23.3Projected Trends Baseline - 2016 :  23.8Projected Trends Baseline - 2015 :  24.3Projected Trends Baseline - 2014 :  24.8Projected Trends Baseline - 2013 :  25.3Projected Trends Baseline - 2012 :  26.0Projected Trends Baseline - 2011 :  26.6Projected Trends Baseline - 2010 :  27.2Projected Trends Baseline - 2009 :  27.9Projected Trends Baseline - 2008 :  28.8Projected Trends Baseline - 2007 :  29.3Projected Trends Baseline - 2006 :  30.3Projected Trends Baseline - 2005 :  31.1Projected Trends Baseline - 2004 :  31.8Projected Trends Baseline - 2003 :  32.7Projected Trends Baseline - 2002 :  33.4US Vital Statistics - 2002 :  33.4US Vital Statistics - 2001 :  33.2US Vital Statistics - 2000 :  34.9Healthy People 2010 U.S. Target - 2010 :  13.7

Download: data | image[D]

Similar graphs for white men and black women show that while pursuing interventions more aggressively WILL reduce mortality more quickly, in neither case is it sufficient to meet the HP 2010 mortality objective of 13.7 deaths per 100,000.

Graphs showing the White Males results for the combined (average) model. The scenarios displayed are the the projected trends baseline, Risk Factors, Screening and Chemotherapy (Optimistic Goals) and Risk Factors, Screening and Chemotherapy* (HP 2010 Goals)Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2020 :  11.6Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2019 :  11.9Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2018 :  12.3Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2017 :  12.6Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2016 :  13.1Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2015 :  13.6Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2014 :  14.0Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2013 :  14.6Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2012 :  15.3Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2011 :  16.0Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2010 :  16.8Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2009 :  17.5Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2008 :  18.3Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2007 :  19.1Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2006 :  20.0Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2005 :  21.0Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2004 :  21.9Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2003 :  22.6Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2002 :  23.2Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2020 :  11.4Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2019 :  11.9Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2018 :  12.2Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2017 :  12.7Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2016 :  13.1Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2015 :  13.6Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2014 :  14.1Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2013 :  14.6Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2012 :  15.4Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2011 :  16.1Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2010 :  16.9Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2009 :  17.7Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2008 :  18.5Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2007 :  19.4Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2006 :  20.2Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2005 :  21.0Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2004 :  21.9Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2003 :  22.6Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2002 :  23.2Projected Trends Baseline - 2020 :  13.0Projected Trends Baseline - 2019 :  13.2Projected Trends Baseline - 2018 :  13.5Projected Trends Baseline - 2017 :  13.7Projected Trends Baseline - 2016 :  14.2Projected Trends Baseline - 2015 :  14.6Projected Trends Baseline - 2014 :  15.0Projected Trends Baseline - 2013 :  15.4Projected Trends Baseline - 2012 :  16.1Projected Trends Baseline - 2011 :  16.7Projected Trends Baseline - 2010 :  17.4Projected Trends Baseline - 2009 :  18.1Projected Trends Baseline - 2008 :  18.8Projected Trends Baseline - 2007 :  19.7Projected Trends Baseline - 2006 :  20.5Projected Trends Baseline - 2005 :  21.3Projected Trends Baseline - 2004 :  21.9Projected Trends Baseline - 2003 :  22.6Projected Trends Baseline - 2002 :  23.2US Vital Statistics - 2002 :  23.2US Vital Statistics - 2001 :  23.7US Vital Statistics - 2000 :  24.4Healthy People 2010 U.S. Target - 2010 :  13.7

Download: data | image[D]

Graphs showing the Black Females results for the combined (average) model. The scenarios displayed are the the projected trends baseline, Risk Factors, Screening and Chemotherapy (Optimistic Goals) and Risk Factors, Screening and Chemotherapy* (HP 2010 Goals)Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2020 :  11.1Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2019 :  11.2Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2018 :  11.6Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2017 :  12.1Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2016 :  12.7Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2015 :  13.1Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2014 :  13.7Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2013 :  14.2Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2012 :  14.8Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2011 :  15.4Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2010 :  16.4Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2009 :  17.1Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2008 :  17.8Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2007 :  18.4Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2006 :  19.2Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2005 :  20.0Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2004 :  21.3Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2003 :  22.2Risk Factors, Screening and Chemotherapy* (HP 2010 Goals) - 2002 :  22.8Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2020 :  12.3Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2019 :  12.4Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2018 :  12.7Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2017 :  13.1Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2016 :  13.6Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2015 :  13.9Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2014 :  14.4Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2013 :  14.8Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2012 :  15.4Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2011 :  15.9Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2010 :  16.6Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2009 :  17.3Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2008 :  18.0Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2007 :  18.6Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2006 :  19.3Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2005 :  20.1Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2004 :  21.4Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2003 :  22.2Risk Factors, Screening and Chemotherapy (Optimistic Goals) - 2002 :  22.8Projected Trends Baseline - 2020 :  13.6Projected Trends Baseline - 2019 :  13.7Projected Trends Baseline - 2018 :  14.1Projected Trends Baseline - 2017 :  14.2Projected Trends Baseline - 2016 :  14.6Projected Trends Baseline - 2015 :  14.9Projected Trends Baseline - 2014 :  15.3Projected Trends Baseline - 2013 :  15.7Projected Trends Baseline - 2012 :  16.2Projected Trends Baseline - 2011 :  16.6Projected Trends Baseline - 2010 :  17.3Projected Trends Baseline - 2009 :  18.0Projected Trends Baseline - 2008 :  18.8Projected Trends Baseline - 2007 :  19.3Projected Trends Baseline - 2006 :  20.1Projected Trends Baseline - 2005 :  20.6Projected Trends Baseline - 2004 :  21.4Projected Trends Baseline - 2003 :  22.2Projected Trends Baseline - 2002 :  22.8US Vital Statistics - 2002 :  22.8US Vital Statistics - 2001 :  24.2US Vital Statistics - 2000 :  23.9Healthy People 2010 U.S. Target - 2010 :  13.7

Download: data | image[D]

NIH… Turning Discovery Into Health®